For men dealing with the aftermath of stroke, traumatic brain injury (TBI), multiple sclerosis (MS), or spinal cord injury, muscle spasticity — the involuntary stiffness and spasms that make limbs difficult to move and control — is one of the most functionally limiting and painful complications. Botox is FDA-approved to treat upper and lower limb spasticity in adults, and for many men, it's the most effective tool available to reduce muscle tone, improve range of motion, ease pain, and make rehabilitation more effective. Yet it remains underutilized — many men and their families don't know this option exists or how to access it.
What Is Spasticity and Who Is Affected?
Spasticity is a motor disorder characterized by velocity-dependent increased muscle tone — muscles that resist passive stretching and contract involuntarily. It results from damage to the descending motor pathways in the brain or spinal cord, which normally exert inhibitory control over spinal reflex activity. Without this control, muscles become hyperreactive and spastic. Spasticity affects approximately 12 million people worldwide, predominantly affecting the upper extremities (arm spasticity: wrist flexion, elbow flexion, finger curling) and lower extremities (leg spasticity: equinovarus foot, knee extension, hip adduction). Men affected by stroke, TBI, MS, and spinal cord injury represent a significant proportion of this population.
How Botox Treats Spasticity
Ready to find a provider near you?
Search by Zip Code →Botox reduces spasticity by blocking acetylcholine release at the neuromuscular junction in the targeted spastic muscles, reducing their involuntary contractile activity and decreasing muscle tone. Unlike oral antispasticity medications (baclofen, tizanidine), which affect the entire body and produce significant sedation and weakness, Botox works locally — only the injected muscles are affected. This allows for targeted reduction of the problematic spastic muscles while preserving function in adjacent muscles that are working correctly. A physiatrist or neurologist performs the injections, typically using electromyography (EMG) or ultrasound guidance to precisely identify and inject the target muscles.
FDA approvals for spasticity Botox: onabotulinumtoxinA (Botox) is approved for upper limb spasticity in adults since 2010 and lower limb spasticity in adults since 2016. AbobotulinumtoxinA (Dysport) has similar approvals. These are well-established, covered medical indications — not experimental or off-label for adult spasticity.
Conditions Treated With Spasticity Botox in Men
Botox for spasticity is used across these conditions:
- •Stroke — the most common indication; upper and lower limb spasticity after ischemic or hemorrhagic stroke
- •Traumatic brain injury (TBI) — including sports injuries, motor vehicle accidents, falls
- •Multiple sclerosis (MS) — spasticity is one of the most common and debilitating MS symptoms
- •Spinal cord injury — incomplete injuries often produce significant lower limb spasticity
- •Cerebral palsy (adults) — adults with CP continue to benefit from spasticity management
- •Neurodegenerative conditions — spasticity components in certain hereditary and acquired motor neuron disorders
Ready to find a provider near you?
Search by Zip Code →What to Expect From Treatment
Spasticity Botox injections are typically performed in a physiatry (physical medicine and rehabilitation) or neurology clinic setting. Sessions involve injecting multiple target muscles per area — in upper limb spasticity, this might mean treating the wrist flexors, elbow flexors, and finger flexors in a single session. Dosing is significantly higher than cosmetic use — stroke patients may receive 200-400 units per session (vs. 20-60 for cosmetic). Effects begin within 1-2 weeks and last 3-6 months. Treatment is combined with physical and occupational therapy — Botox reduces the muscle tone that limits therapy effectiveness, allowing the therapy to achieve better outcomes during the treatment window. Repeat treatments are typically every 3-4 months.
Insurance Coverage and Access
Because spasticity Botox is FDA-approved for these indications and medically necessary for qualifying patients, it is typically covered by Medicare, Medicaid, and private insurance. Prior authorization is generally required, documenting the underlying neurological condition, the specific muscles causing functional impairment, and prior conservative treatment. Men or their caregivers should work with their physiatrist or neurologist to navigate the prior authorization process — these specialists are experienced with the documentation required. If denied, appeal with detailed functional impact documentation. The cost without insurance can be significant ($2,000-5,000 per session at full dose), making coverage navigation critical. Ask your neurologist or physiatrist for a referral — find a starting point at /find-botox-near-me.
Ready to find a provider near you?
Search by Zip Code →The Rehabilitation Partnership: Botox Plus Physical Therapy
Botox alone is not a spasticity rehabilitation program — it's a tool that enables better therapy outcomes. The treatment window (weeks 2-12 post-injection) is when the reduction in muscle tone is most significant, and this is the window to intensify physical therapy, occupational therapy, and stretching programs. Botox relaxes the spastic muscles; therapy and functional training teach the brain and neuromuscular system to use that newly available range of motion. Men who combine regular Botox treatment cycles with consistent rehabilitation consistently outperform those who use either in isolation. The long-term goal is progressive functional improvement over treatment cycles, not just temporary tone reduction.